Trial Pairing Trametinib and HDM201 in Colorectal Cancer Halts Early
A phase I dose-escalation trial evaluating trametinib combined with HDM201 in advanced colorectal cancer ended early due to slow accrual, ...
A phase I dose-escalation trial evaluating trametinib combined with HDM201 in advanced colorectal cancer ended early due to slow accrual, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.